Lorazepam: No dose adjustment is needed for mild-to-moderate liver impairment; not encouraged for patients with hepatic failureWeigh the profit vs. the potential risk of ongoing therapy; if vital, consider an agent with a short fifty percent-life, and use sparingly and intermittentlySide effects that commonly do not call for healthcare consideratio